[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"hematologic-neoplasm\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:hematologic-neoplasm":27},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,3,0,[8,52,95],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":31,"overallStatus":39,"whyStopped":4,"lastUpdateSubmitDate":40,"lastUpdatePostDateStruct":41,"startDateStruct":44,"completionDateStruct":46,"leadSponsor":48,"locationsCount":51},"100639616","hematocare-feasibility-of-a-survivorship-care-plan-for-hematologic-cancer-patients-undergoing-hsct-100639616",false,"NCT07579065","HematoCare: Feasibility of a Survivorship Care Plan for Hematologic Cancer Patients Undergoing HSCT","Survivorship Care in Patients With Hematologic Cancer Undergoing HSCT: A Feasibility Study on Quality of Life, Unmet Needs, and Caregivers Burden","HematoCare","Inclusion Criteria:\n\n* Patients with hematologic cancer candidates for HSCT (autologous or allogeneic) and their informal caregivers\n* Able to provide informed consent\n* Able to communicate in Italian\n\nExclusion Criteria:\n\n* Patients or caregivers with comorbidities hindering participation (e.g., significant cognitive limitations)","ALL","18 Years",{"count":20,"type":21},40,"ESTIMATED","INTERVENTIONAL",[24],"NA","This is a feasibility study to implement a Survivorship Care (SC) Plan for patients with hematologic cancer undergoing hematopoietic stem cell transplantation (HSCT). The study evaluates if the intervention is feasible within the Italian national health system, focusing on retention rates, quality of life, unmet needs and caregiver burden",[27,28,29,30],"Hematologic Neoplasm","Hematopoietic Stem Cell Transplantation","Survivorship","Cancer Survivorship",[32,33,34,35,36,37,38],"Hematologic Malignancies","Survivorship Care","Quality of Life","Caregiver Burden","Unmet Needs","Feasibility Study","Patient Reported Outcome Measures (PROMs)","RECRUITING","2026-07-23",{"date":42,"type":43},"2026-07-24","ACTUAL",{"date":45,"type":21},"2026-06",{"date":47,"type":21},"2028-01",{"name":49,"class":50},"Azienda USL Reggio Emilia - IRCCS","OTHER_GOV",1,{"id":53,"slug":54,"hasResults":11,"nctId":55,"briefTitle":56,"officialTitle":57,"acronym":4,"eligibilityCriteria":58,"healthyVolunteers":59,"sex":17,"minAge":18,"maxAge":60,"enrollmentInfo":61,"targetDuration":4,"studyType":63,"phases":4,"briefSummary":64,"conditions":65,"keywords":73,"overallStatus":84,"whyStopped":4,"lastUpdateSubmitDate":85,"lastUpdatePostDateStruct":86,"startDateStruct":88,"completionDateStruct":90,"leadSponsor":92,"locationsCount":51},"100647771","rutgers-university-study-of-the-genetics-of-blood-cancers-100647771","NCT07714044","Rutgers University Study of the Genetics of Blood Cancers","The Rutgers University Study of the Genetics of Blood Cancers","Inclusion Criteria:\n\n* age 18 years or older\n* currently living in the United States\n* have access to the internet and a computer, laptop, tablet or smartphone\n* willing to provide written informed consent for participation\n* willing to provide DNA via a saliva sample using a collection kit mailed to your home\n* willing to complete a survey with questions about health related to the study of blood cancer.\n\nExclusion Criteria:\n\n* Not able to meet or fulfill any of the inclusion criteria",true,"110 Years",{"count":62,"type":21},10000,"OBSERVATIONAL","The goal of this study is to enroll at least 10,000 participants nationally including affecteds and unaffecteds via online study portal, collect surveys online and a saliva sample through the mail, sequence DNA, and conduct genetic analyses to identify novel variants and further study known variants associated with leukemia, lymphoma, myeloma and other blood cancers.",[66,67,68,69,70,71,32,27,72],"Blood Cancers","Blood Cancer","Leukemia","Lymphoma","Myeloma","Hematologic Cancer","Hematologic Tumors",[74,75,76,77,78,79,80,81,82,83],"genetics","blood cancer","blood cancers","leukemia","lymphoma","myeloma","hematologic cancer","hematologic malignancy","hematologic tumor","hematologic neoplasm","NOT_YET_RECRUITING","2026-07-15",{"date":87,"type":43},"2026-07-20",{"date":89,"type":21},"2026-08",{"date":91,"type":21},"2029-08",{"name":93,"class":94},"Rutgers, The State University of New Jersey","OTHER",{"id":96,"slug":97,"hasResults":11,"nctId":98,"briefTitle":99,"officialTitle":100,"acronym":101,"eligibilityCriteria":102,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":103,"targetDuration":4,"studyType":63,"phases":4,"briefSummary":105,"conditions":106,"keywords":108,"overallStatus":39,"whyStopped":4,"lastUpdateSubmitDate":113,"lastUpdatePostDateStruct":114,"startDateStruct":116,"completionDateStruct":118,"leadSponsor":120,"locationsCount":51},"100594086","factors-associated-with-health-related-quality-of-life-and-social-participation-of-patients-with-multiple-myeloma-and-their-caregivers-100594086","NCT07014865","Factors Associated With Health-related Quality of Life and Social Participation of Patients With Multiple Myeloma and Their Caregivers","Factors Associated With Health-related Quality of Life and Social Participation of Patients With Multiple Myeloma and Their Caregivers: a Mixed Methods Study","MMYLIFE","Inclusion criteria for individuals with MM will be:\n\n1. diagnosis of MM\n2. adulthood (≥ 18 years)\n3. in treatment (LOT I, II, or ≥ III) at the Hematology Unit\n4. speak Italian fluently\n\nExclusion Criteria:\n\nComorbidities that limit collaboration (e.g., dementia, severe psychiatric disorders).\n\n\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\n\nInclusion criteria for caregiver will be:\n\n1. having a loved one (individual with MM) who have participated in the quantitative phase\n2. being the primary informal caregiver\n3. adulthood (≥ 18 years)\n4. speak Italian fluently",{"count":104,"type":21},190,"Individuals with multiple myeloma (MM) are vulnerable because of the effects of systemic organ damage and the side effects of treatment. A decline in patients' health-related quality of life (HRQoL) and a compromised participation in everyday life was reported. The diagnosis of MM negatively affects the principal informal caregiver. This is a concurrent exploratory mixed methods study that involves the use of a quantitative and a qualitative approach. For the quantitative study, aims are to describe any possible relation between the identified factors with HRQoL and participation in individuals with MM and with reactions to caring and self-efficacy of caregivers. For the qualitative study, aims are to investigate \"how\" and \"why\" the disease impacts the daily life of individuals with MM and their caregivers. The final analyses will be based on the comparison of the results of the quantitative phase and the results of the qualitative phase.",[107,27],"Multiple Myeloma (MM)",[34,109,110,111,112],"Social Participation","Caregivers","Observational study","Qualitative Research","2025-08-28",{"date":115,"type":43},"2025-08-29",{"date":117,"type":43},"2025-06-17",{"date":119,"type":21},"2027-01",{"name":49,"class":50}]